Cargando…

ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathway

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is one of the prevalent and deadly cancers worldwide. Previous studies confirmed that endothelin-1 (ET-1) serves as an oncogene and therapeutic target in various tumors. However, the role and mechanism of ET-1 in the progression of ESCC remains l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Hui, Wang, Lunqing, Li, Fei, Wang, Dongfei, Zhang, Zhe, Yu, Bentong, Liu, Yange
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799244/ https://www.ncbi.nlm.nih.gov/pubmed/35117695 http://dx.doi.org/10.21037/tcr.2020.04.26

Ejemplares similares

HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway
por: Wang, Hongqiang, et al.
Publicado: (2019)

Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma
por: Fan, Zhiqin, et al.
Publicado: (2023)

Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy
por: Li, Bin, et al.
Publicado: (2017)

Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway
por: Qiao, Zhongshi, et al.
Publicado: (2022)

BRE Promotes Esophageal Squamous Cell Carcinoma Growth by Activating AKT Signaling
por: Jin, Fujun, et al.
Publicado: (2020)

CEP55 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma via the PI3K/Akt pathway
por: Jia, Yang, et al.
Publicado: (2018)

Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling
por: Liu, Yingge, et al.
Publicado: (2020)

NETO2 promotes esophageal cancer progression by inducing proliferation and metastasis via PI3K/AKT and ERK pathway
por: Xu, Jia-cheng, et al.
Publicado: (2021)

Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway
por: Guo, Jida, et al.
Publicado: (2022)

Baicalein induces apoptosis in esophageal squamous cell carcinoma cells through modulation of the PI3K/Akt pathway
por: ZHANG, HONG-BO, et al.
Publicado: (2013)

Tetraspanin 1 (TSPAN1) promotes growth and transferation of breast cancer cells via mediating PI3K/Akt pathway
por: Wu, Yange, et al.
Publicado: (2021)

Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma via the PI3K/AKT pathway
por: Hu, Dong-Xin, et al.
Publicado: (2022)

Corrigendum: Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway
por: Guo, Jida, et al.
Publicado: (2022)

PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling
por: Wang, Mengmeng, et al.
Publicado: (2023)

Suppression of esophageal tumor growth and chemoresistance by directly targeting the PI3K/AKT pathway
por: Li, Bin, et al.
Publicado: (2014)

STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling
por: Yang, Shuwen, et al.
Publicado: (2016)

XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway
por: Jian, Jie, et al.
Publicado: (2020)

The Synthetic β-Nitrostyrene Derivative CYT-Rx20 Inhibits Esophageal Tumor Growth and Metastasis via PI3K/AKT and STAT3 Pathways
por: Chiu, Wen-Chin, et al.
Publicado: (2016)

HMGB1 induces radioresistance through PI3K/AKT/ATM pathway in esophageal squamous cell carcinoma
por: Zhang, Xueyuan, et al.
Publicado: (2022)

ZNF692 promotes colon adenocarcinoma cell growth and metastasis by activating the PI3K/AKT pathway
por: Xing, Yanwei, et al.
Publicado: (2019)

TROP2 increases growth and metastasis of human oral squamous cell carcinoma through activation of the PI3K/Akt signaling pathway
por: Tang, Genxiong, et al.
Publicado: (2019)

Anlotinib Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting the RAS Protein to Inhibit the PI3K/Akt Signalling Pathway
por: Lu, Yunfei, et al.
Publicado: (2021)

RPN2 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis via the PI3K-Akt Pathway
por: Han, Chenglin, et al.
Publicado: (2021)

AKR1C2 acts as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway
por: Zhang, Zhan‐Fei, et al.
Publicado: (2020)

The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma
por: Wu, Ning, et al.
Publicado: (2018)

CD147 promotes glucose metabolism, invasion and metastasis via PI3K/AKT pathway in oral squamous cell carcinomas
por: Huang, Yi, et al.
Publicado: (2019)

Inhibition of esophageal cancer growth through the suppression of PI3K/AKT/mTOR signaling pathway
por: Shi, Ni, et al.
Publicado: (2019)

Exosomal lncRNA HOTAIR induce macrophages to M2 polarization via PI3K/ p-AKT /AKT pathway and promote EMT and metastasis in laryngeal squamous cell carcinoma
por: Wang, Jingting, et al.
Publicado: (2022)

Cholesterol Promotes Colorectal Cancer Growth by Activating the PI3K/AKT Pathway
por: Wu, Cheng, et al.
Publicado: (2022)

Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling
por: Wang, Yan, et al.
Publicado: (2018)

TrkB promotes laryngeal cancer metastasis via activation PI3K/AKT pathway
por: Jiang, Liang, et al.
Publicado: (2017)

PLEK2 promotes osteosarcoma tumorigenesis and metastasis by activating the PI3K/AKT signaling pathway
por: Liu, Yang, et al.
Publicado: (2021)

Rap1A promotes esophageal squamous cell carcinoma metastasis through the AKT signaling pathway
por: Li, Qinfang, et al.
Publicado: (2019)

CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway
por: Zhang, Li Q., et al.
Publicado: (2019)

MicroRNA-101 inhibits growth and metastasis of human ovarian cancer cells by targeting PI3K/AKT
por: Wei, Min, et al.
Publicado: (2019)

LSD1 regulates Notch and PI3K/Akt/mTOR pathways through binding the promoter regions of Notch target genes in esophageal squamous cell carcinoma
por: Hou, Guiqin, et al.
Publicado: (2019)

Loss of miR-204-5p Promotes Tumor Proliferation, Migration, and Invasion Through Targeting YWHAZ/PI3K/AKT Pathway in Esophageal Squamous Cell Carcinoma
por: Shen, Zhimin, et al.
Publicado: (2020)

MicroRNA-195 suppresses rectal cancer growth and metastasis via regulation of the PI3K/AKT signaling pathway
por: Wang, Yeli, et al.
Publicado: (2019)

GABARAPL1 suppresses metastasis by counteracting PI3K/Akt pathway in prostate cancer
por: Su, Wei, et al.
Publicado: (2016)

A Circ-0007022/miR-338-3p/Neuropilin-1 Axis Reduces the Radiosensitivity of Esophageal Squamous Cell Carcinoma by Activating Epithelial-To-Mesenchymal Transition and PI3K/AKT Pathway
por: Zhang, Junpeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sigl195fa7uqin9pdrjja3v843